Today: 9 June 2026
Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

New York, Jan 5, 2026, 14:29 EST — Regular session

Fabrinet (NYSE:FN) shares fell about 6.7% on Monday, bucking a rise in the broader market. The stock was down $32.06 at $447.36 by 2:29 p.m. EST, after swinging between $490.18 and $440.00. The S&P 500 and Nasdaq were up about 0.7% and 0.8%, respectively.

The move matters because Fabrinet sits deep in the hardware supply chain, providing optical packaging — the assembly and testing of optical components — and other precision manufacturing services for complex products. That leaves the stock sensitive to shifts in demand from equipment makers serving telecom networks, data links and industrial markets, LSEG data on Reuters showed.

Investors are also positioning ahead of Fabrinet’s next quarterly update for the period that ended Dec. 26, after management laid out an aggressive target for the December quarter. Fabrinet said in a Nov. 3 release it expected second-quarter revenue of $1.05 billion to $1.10 billion, after first-quarter revenue hit a record $978.1 million and non-GAAP earnings per share — which exclude certain items — came in at $2.92.

The slide was broad across electronics manufacturing services, or EMS — contract makers that build products for other companies. Jabil fell 6.9%, Celestica lost 5.0% and Flex dropped 3.5%.

Jabil said it completed a cash acquisition of Hanley Energy Group for about $725 million, plus up to $58 million of contingent payments tied to revenue thresholds. The deal adds power-management and energy-optimization capabilities that Jabil said will help expand rack-level data center infrastructure offerings.

Macro data also sharpened investor focus on capital spending. The Institute for Supply Management said its manufacturing purchasing managers index (PMI) slipped to 47.9 in December; a reading below 50 signals contraction. “We remain cautious on the extent of recovery in traditional cap-ex categories this year,” Wells Fargo economist Shannon Grein said, referring to capex, or capital expenditures.

But Fabrinet’s next report will do most of the talking for the stock. Any sign that demand is cooling, or that costs are squeezing margins, would challenge a name investors have priced for continued growth.

Stock Market Today

  • Applied Materials 10-Year Investment Growth: $1000 to $20,312
    June 9, 2026, 10:25 AM EDT. A $1000 investment in Applied Materials (AMAT) made in June 2016 would be worth $20,312.42 as of June 2026, representing a 1,931.24% gain. Applied Materials, based in Santa Clara, California, supplies equipment for semiconductor device manufacturing, flat panel displays and solar PV products. Its business is divided into Semiconductor Systems, Applied Global Services, and Display segments. The company's tools support critical chipmaking processes, including deposition and implantation on silicon wafers. With over 33,000 systems installed globally, it competes mainly with equipment makers like KLAC and LRCX. This significant return highlights the potential rewards of long-term investment in semiconductor capital equipment providers.

Latest articles

Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR
Previous Story

NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR

3.5 million hit by University of Phoenix data breach as school rolls out “credit for prior learning” push
Next Story

3.5 million hit by University of Phoenix data breach as school rolls out “credit for prior learning” push

Go toTop